The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Xyzal 5 mg/ml oral drops, solution



UCB (Pharma) Ireland LimitedPA0891/003/002

Main Information

Trade NameXyzal 5 mg/ml oral drops, solution
Active SubstancesLevocetirizine dihydrochloride
Dosage FormOral drops, solution
Licence HolderUCB (Pharma) Ireland Limited
Licence NumberPA0891/003/002

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE09 levocetirizine

Status

License statusAuthorised
Licence Issued02/12/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back